E-Learning

Vaccine stocks muted as investors assess Kennedy's overhaul of key panel

(Reuters) -Shares of global vaccine makers were mixed on Tuesday, as investors assessed U.S. Health Secretary Robert F. Kennedy Jr.'s surprising decision to fire all 17 members of a key expert panel late on Monday. Shares of U.S. vaccine maker Moderna fell 2%, while Novavax was down marginally. Merck and Pfizer rose between 1.4% and 2%.

Read more